Review
Large-vessel vasculitis: Unresolved issues
Gary S. Hoffman,
Corresponding Author
Gary S. Hoffman
Cleveland Clinic Foundation, Cleveland, Ohio
Harold C. Schott Chair of Rheumatic and Immunologic Diseases, Director, Center for Vasculitis Care and Research, Cleveland Clinic Foundation/A50, Cleveland, OH 44195Search for more papers by this authorGary S. Hoffman,
Corresponding Author
Gary S. Hoffman
Cleveland Clinic Foundation, Cleveland, Ohio
Harold C. Schott Chair of Rheumatic and Immunologic Diseases, Director, Center for Vasculitis Care and Research, Cleveland Clinic Foundation/A50, Cleveland, OH 44195Search for more papers by this author
REFERENCES
- 1 Osler W. In: Modern medicine, its theory and practice. Philadelphia: Lea and Febiger; 1908.
- 2 Ibn Isa A. Memorandum book of a tenth-century oculist for the use of modern ophthalmologists. CA Wood, translator. Chicago: Northwestern University Press; 1936. p. 225.
- 3 Horton BT, Magath TB, Brown GE. An undescribed form of arteritis of temporal vessels. Mayo Clin Proc 1932; 7: 700–1.
- 4 Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919–29.
- 5 Rojo-Leyva F, Ratliff NB, Cosgrove DM III, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 2000; 43: 901–7.
- 6 Svensjo S, Bengtsson H, Bergqvist D. Thoracic and thoracoabdominal aortic aneurysm and dissection: investigation based on autopsy. Br J Surg 1996; 83: 68–71.
- 7 Ostberg G. An arteritis with special reference to polymyalgia rheumatica. Acta Pathol Microbiol Scand [A] 1973; 237 Suppl 237: 1–59.
- 8 Bickerstaff LK, Pairolero PC, Hollier LH, Melton J, Van Peenen HJ, Cherry KJ, et al. Thoracic aortic aneurysms: a population-based study. Surgery 1982; 92: 1103–8.
- 9 Pomerance A, Yacoub MH, Gula G. The surgical pathology of thoracic aortic aneurysms. Histopathology 1997; 1: 257–76.
- 10 Okuyama K, Yaginuma G, Takahashi T, Sasaki H, Mori S. The development of vasa vasorum of the human aorta in various conditions: a morphometric study. Arch Pathol Lab Med 1988; 112: 721–5.
- 11 Schutte HE. Changes in the vasa vasorum of the atherosclerotic aortic wall. Angiologica 1968; 5: 210–22.
- 12 Fischer GM, Swain ML, Cherian K. Increased collagen and elastin synthesis in experimental atherosclerosis in the rabbit: variation in synthesis among major vessels. Atherosclerosis 1980; 35: 11–20.
- 13 Sokolis DP, Boudoulas H, Kavantzas NG, Kostomitsopulous N, Agapitos EV, Karayannacos PE. A morphometric study of the structural characteristics of the aorta in pigs using an image analysis method. Anat Histol Embryol 2002; 31: 21–30.
- 14 Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS, et al. A critical role for elastin signaling in vascular morphogenesis and disease. Development 2003; 130: 411–23.
- 15 Schlatmann T, Becker A. Pathogenesis of dissecting aneurysm of aorta: comparative histopathologic study of significance of medial changes. Am J Cardiol 1977; 39: 21–6.
- 16 Haimovici H, Maier N. Role of arterial tissue susceptibility in experimental canine atherosclerosis. J Atherosclerosis Res 1966; 6: 62–74.
- 17 Oz MC, Brener BJ, Buda JA, Todd G, Brenner RW, Goldenkranz RJ, et al. A ten-year experience with bacterial aortitis. J Vasc Surg 1989; 10: 439–49.
- 18 Heggtveit HA. Syphilitic aortitis: a clinicopathologic autopsy study of 100 cases, 1950-1960. Circulation 1964; 29: 346–55.
- 19 Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol 1994; 48: 585–617.
- 20 Brown EL, Wooten RM, Johnson BJ, Iozzo RV, Smith A, Dolan MC, et al. Resistance to Lyme disease in decorin-deficient mice. J Clin Invest 2001; 107: 845–52.
- 21 Misiani R. Virus-associated vasculitides: pathogenesis. In: GS Hoffman, CM Weyand, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p. 553–63.
- 22 Vassiloppoulos D, Calabrese LH. Virus-associated vasculitides: clinical aspects. In: GS Hoffman, CM Weyand, editors. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002. p. 565–97.
- 23 Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL. Association between polyarteritis and Australia antigen. Lancet 1970; 2: 1149–53.
- 24 Trepo C, Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 1970; 19: 410–1.
- 25 Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 1987; 316: 965–70.
- 26 Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294–8.
- 27 Feldman M. Hepatitis B virus. In: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia: Saunders; 1998. p. 1129–44.
- 28 Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40: 2007–15.
- 29 Kikuta H, Sakiyama Y, Matsumoto S, Hamada I, Yazaki M, Iwaki T, et al. Detection of Epstein-Barr virus DNA in cardiac and aortic tissues from chronic, active Epstein-Barr virus infection associated with Kawasaki disease-like coronary artery aneurysms. J Pediatr 1993; 123: 90–2.
- 30 Murakami K, Ohsawa M, Hu S-X, Kanno H, Aozasa K, Nose M. Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum 1998; 41: 369–73.
- 31 Henson JB, Gorham JR. Animal model of human disease. Am J Pathol 1973; 71: 345–8.
- 32 Henson JB, Crawford TB. The pathogenesis of viral-induced arterial disease: Aleutian disease and equine viral arteritis. Adv Cardiol 1974; 13: 183–91.
- 33 Hadlow WJ, Race RE, Kennedy RC. Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun 1983; 41: 1016–23.
- 34 Weck KE, Dal Canto AJ, Gould JD, O'Guin AK, Roth KA, Saffitz JE, et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 1997; 3: 1346–53.
- 35 Dal Canto AJ, Swanson PE, O'Guin AK, Speck SH, Virgin HW. IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site. J Clin Invest 2001; 107: R15–22.
- 36 Dal Canto AJ, Virgin HW, Speck SH. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol 2000; 74: 11304–10.
- 37 Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW. Interferon-alpha regulates acute and latent murine cytomegalovirus infection and chronic disease of great vessels. J Exp Med 1998; 188: 577–88.
- 38 Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff GW. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med 2000; 191: 303–11.
- 39 Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191: 313–20.
- 40 Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Opin Rheumatol 1997; 9: 3–11.
- 41 Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM. Giant cell arteritis is a T cell-dependent disease. Mol Med 1997; 3: 530–43.
